MedImmune, LLC
One MedImmune Way
Gaithersburg
Maryland
20878
United States
Tel: 301-398-0000
Fax: 301-398-9000
Website: http://www.medimmune.com/
About MedImmune, LLC
MedImmune is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom, and the Netherlands. UK facilities include vaccine manufacturing operations in Speke and antibody discovery and research laboratories in Cambridge.
With two marketed products and an advancing pipeline of promising candidates in the areas of infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience, MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees.
352 articles about MedImmune, LLC
-
MedImmune, Inc. Fills Senior Marketing And Sales Post
5/22/2006
-
MedImmune, Inc. To Present At The Bank of America 2006 Health Care Conference
5/10/2006
-
MedImmune, Inc. Chairman And Founder Receives Leadership Excellence Award From Robert H. Smith School Of Business
5/5/2006
-
MedImmune, Inc. Awarded $170 Million, Five-Year Contract From U.S. Department of Health and Human Services To Develop Cell-Based Influenza Vaccines
5/4/2006
-
Phase 3 Study Results Of MedImmune, Inc.'s Next-Generation Influenza Vaccine Suggest Better Relative Efficacy Against Matched And Mismatched Strains Compared To The Flu Shot In Young Children
5/1/2006
-
MedImmune, Inc. Presents New Data From Pediatric Studies With FluMist(R) At Pediatric Academic Societies Annual Meeting
5/1/2006
-
MedImmune, Inc. Awards Fellowship Grants In Pediatric Research Totaling $210,000
5/1/2006
-
MedImmune, Inc. And Pediatric Infectious Diseases Society Present 'MedImmune, Inc. Career Development Award' To Children's Hospital of Philadelphia Pediatrician
5/1/2006
-
MedImmune, Inc. To Present At Two Upcoming Healthcare Conferences
4/21/2006
-
The Day In Review: Dynavax Technologies Corporation Gets Creative Funding
4/20/2006
-
MedImmune, Inc. Reports Financial Results For First Quarter 2006
4/20/2006
-
MedImmune, Inc. Begins Dosing Of Lupus Patients In Phase 1 Clinical Trial
4/13/2006
-
Lynbrook High School Junior Receives Science Award From MedImmune, Inc.
4/12/2006
-
MedImmune, Inc. Release: Additional Preclinical And Clinical Data Indicate Abegrin(TM) May Offer Three-Pronged Approach To Cancer Therapy
4/10/2006
-
MedImmune, Inc. Sponsors American Association for Cancer Research Fellowship Grant For Research On Biologics-Based Cancer Therapies
4/5/2006
-
MedImmune, Inc. Adds Substantial Expertise To Commercial Organization With Appointment Of Two New Vice Presidents
4/3/2006
-
MedImmune, Inc. To Announce 2006 First Quarter Financial Results On April 20, 2006
3/29/2006
-
Parkway High School Senior Receives Science Award From MedImmune, Inc.
3/28/2006
-
Montgomery Blair High School Senior Receives Science Award From MedImmune, Inc.
3/21/2006
-
MedImmune, Inc. Broadens Management Team With Five Additional Leaders In Key Strategic Areas
3/15/2006